Founded in 1981, Natco Pharma Limited stands as a vertically integrated pharmaceutical entity with a strong research and development focus. The company’s core activities encompass the development, manufacturing, and marketing of both finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).
Natco Pharma has a distinct emphasis on specialized therapeutic domains and intricate product lines. Their product distribution spans across 40+ countries, including prominent markets like the United States, India, and Europe, where they market their FDF offerings.
In addition to its direct operations, the company extends its presence in strategic regions through subsidiary entities.
Natco Pharma Ltd. Stock Quote #
- Open: ₹916.00
- High – Low: ₹916.00 – ₹867.25
- Previous Close: ₹893.65
- Total Traded Value: 14,52,810
- 52 Weeks High: ₹859.70 (Jul 31, 2023)
- 52 Weeks Low: ₹502.00 (Feb 02, 2023)
- Updated On: Aug 10, 2023 4:00 PM
Natco Pharma Buyback 2023 Detail #
| Issue Period | Mar 21, 2023 – May 12, 2023 |
| Security Name | Natco Pharma Limited |
| Issue Type | Open Market Through Stock Exchange |
| Issue Size (Amount) | ₹210.00 Crores |
| Buyback Price | ₹700 per share |
| Face Value | ₹2 per share |
| Listing At | BSE, NSE |
Company Financials #
| Period Ended | Total Revenue | Profit After Tax | Net Worth |
|---|---|---|---|
| 31-Mar-20 | 2,022.40 | 458.10 | 3,773.50 |
| 31-Mar-21 | 2,155.70 | 442.40 | 4,121.60 |
| 31-Mar-22 | 2,043.80 | 170.00 | 4,263.60 |
| 31-Dec-22 | 1,884.80 | 439.50 | 4,628.20 |
| Amount in ₹ Crore | |||
Stock price at BSE (in preceding 3 months) #
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Feb-2023 | 554.95 | 502.00 | 535.04 |
| Jan-2023 | 570.40 | 526.00 | 545.28 |
| Dec-2022 | 599.00 | 548.00 | 565.78 |
Stock price at NSE (in preceding 3 months) #
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Feb-2023 | 555.00 | 502.00 | 534.88 |
| Jan-2023 | 570.00 | 526.10 | 545.36 |
| Dec-2022 | 600.00 | 547.50 | 565.78 |
Necessity of the Issue #
The Buyback is being undertaken for the following reasons:
- The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares
- The Buyback may help in improving return on equity, by the reduction in the equity base.
- The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.
Natco Pharma Buyback 2023 Documents #
Company Contact Information #
Natco House Road No.2,
Banjara Hills
Hyderabad-500 034Phone: +91-40-2354 7532
Email: investors@natcopharma.co.in
Website: https://www.natcopharma.co.in/
Natco Pharma Buyback 2023 Registrar #
- Venture Capital And Corporate Investments Pvt Ltd
12-10-167,
Bharat Nagar,
Hyderabad, 500018Phone: 040-23818475, 23818476, 23868023
Email: pvsrinivas@vccipl.com
Website: https://www.vccipl.com
